Search

Search Constraints

You searched for: Author/Creator Schooley, Robert T.

Search Results

1. Early clinical experience of bacteriophage therapy in 3 lung transplant recipients. Issue 9 (17th July 2019)

2. Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria. (1st November 2021)

3. Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Issue 3 (4th August 2015)

5. Temporal dynamics of inflammatory cytokines/chemokines during sofosbuvir and ribavirin therapy for genotype 2 and 3 hepatitis C infection. Issue 4 (22nd August 2015)

6. The Medical Education Partnership Initiative (MEPI), a collaborative paradigm for institutional and human resources capacity building between high- and low- and middle-income countries: the Mozambique experience. Issue 1 (1st January 2017)

7. The Medical Education Partnership Initiative Effect on Increasing Health Professions Education and Research Capacity in Mozambique. Issue 1 (30th April 2018)

8. Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial. Issue 6 (15th June 2022)